The Medical College of Wisconsin (MCW) has announced a $5.9 million commitment from the St. Louis-based Paula & Rodger Riney Foundation to advance new scientific and clinical discoveries in multiple myeloma research focused on immunotherapies and long-term survivorship among patients. 

The funding will support cancer research projects during the next two years and promote ongoing advancement of MCW’s work in immunotherapies to treat patients who are long-term survivors of myeloma. For more than two decades, MCW has worked closely with healthcare partners to provide patients research-based myeloma clinical care and access to some of the most pivotal cancer clinical trials and medical discoveries in the country. 

“We are pleased to partner with the MCW Cancer Center in our shared aspiration of finding a cure for multiple myeloma,” said Rodger Riney. “Since the establishment of the foundation, we have sought out the most innovative work in the field, and we are very excited about the promise MCW’s research shows for treating this complex disease.”

(Photo credit: Getty Images/Fat Camera)